Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-06-14 @ 10:29 AM
Study NCT ID:
NCT06832267
Status:
RECRUITING
Last Update Posted:
2025-02-18
First Post:
2025-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
Sponsor:
Organization: